您目前的位置:院首页>首页 > 2013年

2013

2013
  1. Mengyao Li, Hanqing Li, Xiaoliang Cheng, Xipei Wang, Liang Li, Tianyan Zhou*, Wei Lu*(2013) Preclinical Pharmacokinetic/Pharmacodynamic Models to Predict Schedule-Dependent Interaction between Erlotinib and Gemcitabine. Pharm Res. 30(5):1400-1408. (IF= 4.742)
  2. Qiong Wu, Mengyao Li, Hanqing Li, Chenhui Deng, Liang Li, Tianyan Zhou*, Wei Lu*(2013) Pharmacokinetic and pharmacodynamic study of erlotinib based upon phosphorylated epidermal growth factor receptor and tumor volume in human non-small cell lung cancer xenograft mouse mode. Acta Pharmacol Sin. 34:1427–1436. (IF= 2.354)
  3. Xiaoliang Cheng, Liping Guo, Zaiquan Li, Liang Li, Tianyan Zhou*, Wei Lu*(2013) A HPLC method for simultaneous determination of 5-aminoimidazole-4-carboxamide riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in tumor-bearing nude mice plasma and its application to pharmacokinetics study. J Chromatogr B. 915–916:64–70. (IF= 2.487)
  4. Tianyan Zhou, Chaoqun Huang, Yue Chen, Jiaojiao Xu, Preeti Devaraya Shanbhag, Guangping Chen (2013) Methamphetamine Regulation of Sulfotransferase 1A1 and 2A1 Expression in Rat Brain Sections. Neurotoxicology. 34:212-218. (IF 2.652)
  5. Hua Zhang, Yuan Meng, Xueqing Wang, Wenbing Dai, Xinglin Wang, Qiang Zhang. (2013) Pharmaceutical and pharmacpkinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approuches. Drug Del.. DOI:10.3109/10717544.2013.865815(IF= 2.015)
  6. Luo LM, Huang Y, Zhao BX, Zhao X, Duan Y, Du R, Yu KF, Song P, Zhao Y, Zhang X*(2013), Zhang Q. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials. 2013 Jan;34(4):1102-14.(IF=7.604)
  7. Gao Wei, Xiang Bai, Meng Tingting, Liu Feng, Qi Xianrong*. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials. 2013, 34: 4137-4149.
  8. Dong Dawen, Xiang Bai, Gao Wei, Yang Zhenzhen, Li Jingquan Li, Qi Xianrong*. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Biomaterials. 2013, 34: 4849-4859.
  9. Xiang Bai, Dong Dawen, Shi Nianqiu, Gao Wei, Yang Zhenzhen, Cui Yi, Cao Deying, Qi Xianrong Qi*. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials. 2013, 34: 6976-6991.
  10. Zhen-Zhen Yang, Yan-Qing Zhang, Zhan-Zhang Wang, Kai Wu, Jin-Ning Lou, Xian-Rong Qi*. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration. International Journal of Pharmaceutics 452 (2013) 344– 354.
  11. Zhanzhang Wang, Zhenzhen Yang, Xianrong Qi*. Hematological and pathological toxicity of antiHER2/neu-peptide-mimetic modified paclitaxel bovine serum albumin nanoparticles J. Chin. Pharm. Sci. 2013, 22 (5), 441–442 448.
  12. Dong Da-Wen; Tong Shu-Wen; Qi Xian-Rong*, Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers, J Biomed Mater Res Part A, Journal of Biomedical Materials Research, Part A (2013), 101A(5), 1336-1344.
  13. Xiao-Jing Lu, Yuan Zhang, Dai-Chao Cui, Wen-Jing Meng, Ling-Ran Du, Hai-Tao Guan, Zhuo-Zhao Zheng, Nai-Qi Fu, Tian-Shi Lv, Li Songb,Ying-Hua Zou, Wan-Liang Lu, Tian-Yuan Fan* (2013) Research of novel biocompatible radiopaque microcapsules forarterial embolization. Int J Pharm. 452: 211– 219. (IF 3.867)
  14. Bo Zhao, Xue-Qing Wang*, Xiao-You Wang, Hua Zhang, Wen-Bing Dai, Jun Wang, Zhen-Lin Zhong, Hou-Nan Wu*and Qiang Zhang* (2013)Nanotoxicity comparison of four amphiphilic polymeric micelles with similar hydrophilic or hydrophobic structure.Particle and Fibre Toxicology. 10:47. (IF 9.178)
  15. Chao Yu, Bing He, Meng-Hua Xiong, Hua Zhang, Lan Yuan, Ling Ma, Wen-Bing Dai, Jun Wang, Xing-Lin Wang, Xue-Qing Wang*, Qiang Zhang* (2013) The effect of hydrophilic and hydrophobic structure of amphiphilic polymeric micelles on their transport in epithelial MDCK cell. Biomaterials. 34 (26): 6284-6298. (IF 7.604)
  16. Ma X, Zhou J, Zhang CX, Li XY, Li N, Ju RJ, Shi JF, Sun MG, Zhao WY, Mu LM, Yan Y, Lu WL*. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. 2013 Jun;34(18):4452-65.
  17. Chao Fan, Xinru Li, Yanxia Zhou, Yong Zhao, Shujin Ma, Wenjing Li, Yan Liu*, Guiling Li. Enhanced topical delivery of tetrandrine by ethosomes for treatment of arthritis. BioMed Research International. Volume2013, Article ID 161943, 13 pages(IF=2.88)
  18. Bo Zhao, Xueqing Wang, Xiaoyou Wang, Hua Zhang, Wenbing Dai, Jun Wang, ZhenlinZhong, Hounan Wu, Qiang Zhang. (2013) Nanotoxicity comparison of four amphiphilic polymeric micelles with similar hydrophilic or hydrophobic structure. Particle and Fibre Toxicology. Doi: 10.1186/1743-8977-10-47.(IF:9.178)
  19. Chao Yu, Bing He, MenghuaXiong, Hua Zhang, Lan Yuan, Ling Ma, Wenbing Dai, Jun Wang, Xinglin Wang, Xueqing Wang, Qiang Zhang. (2013) The effect of hydrophilic and hydrophobic structure of amphiphilic polymeric micelles on their transport in epithelial MDCK cells. Biomaterials, 34(26): 6284-6298.(IF:7.604)
  20. Bing He, Ping Lin, ZengrongJia, Wenwen Du, Wei Qu, Lan Yuan, Wenbing Dai, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2013) The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials, 34(25):6082-6098. (IF:7.604)
  21. Bing He, ZengrongJia, Wenwen Du, Cao Yu, Yuchen Fan, Wenbing Dai, Lan Yuan, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2013) The transport pathways of polymer nanoparticles in MDCK epithelial cells Biomaterials, 34(17):4309-4326.(IF:7.604)
  22. bet365官方博客bet365体育下注Yuchen Fan, Wenwen Du, Bing He, Fengying Fu, Lan Yuan, Hounan Wu, Wenbing Dai, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2013) The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin. Biomaterials, 34(9):2277-2288. (IF:7.604)
  23. Wenwen Du, Yuchen Fan, Nan Zheng, Bing He, Lan Yuan, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2013) Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery. Biomaterials, 34(3):794-806. (IF:7.604)
  24. Chao Qin,BingHe,WenbingDai,Hua Zhang, Xueqing Wang, Jiancheng Wang, XuanZhang,Guangji Wang, Lifang Yin, Qiang Zhang. (2013) Inhibition of Metastatic Tumor Growth and Metastasis via TargetingMetastatic Breast Cancer by Chlorotoxin-Modified Liposomes. Molecular Pharmaceutics. dx.doi.org/10.1021/mp400691z (IF:4.57)
  25. Zhaohui Wang, Yang Yu, Wenbing Dai, Jingrong Cui, Hounan Wu, Lan Yuan, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang. (2013) A specific peptide ligand-modified lipid nanoparticle carrier for the inhibition of tumor metastasis growth. Biomaterials, 34(3):756-764. (IF:7.604)
  26. Cheng-Jun Chen, Jian-Cheng Wang*, En-Yu Zhao, Ling-Yan Gao, Qiang Feng, Xiao-Yan Liu, Zhi-Xia Zhao, Xiao-Fei Ma, Wen-Jie Hou, Liang-Ren Zhang, Wan-Liang Lu, Qiang Zhang. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery. Biomaterials. 2013 Jul;34(21):5303-16

?